Novel Leech Antimicrobial Peptides, Hirunipins: Real‐Time 3D Monitoring of Antimicrobial and Antibiofilm Mechanisms Using Optical Diffraction Tomography
Advanced Science · 2025-03 · 12 (10)
DOI: 10.1002/advs.202409803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.01.2025. Verfasst von S Dinesh Kumar und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular & Molecular Medicine, School of Medicine, Chosun University, Gwangju, 61452, Republic of Korea. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Anti-Bacterial Agents, Biofilms, Leeches. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education, Ministry of Science and ICT.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) are promising agents for treating antibiotic‐resistant bacterial infections. Although discovering novel AMPs is crucial for combating multidrug‐resistant bacteria and biofilm‐related infections, their clinical potential relies on precise, real‐time evaluation of efficacy, toxicity, and mechanisms. Optical diffraction tomography (ODT), a label‐free imaging technology, enables real‐time visualization of bacterial morphological changes, membrane damage, and biofilm formation over time. Here, a computational analysis of the leech transcriptome using an advanced AI‐based peptide screening strategy with ODT to identify potential AMPs is employed. Among the 19 potential AMPs identified, hirunipin 2 demonstrates potent antibacterial activity, low mammalian cytotoxicity, and minimal hemolytic effects. It demonstrates efficacy comparable to melittin, resistance to physiological salts and human serum, and a low likelihood of inducing bacterial resistance. Microscopy and 3D‐ODT confirm its disruption of bacterial membranes and intracellular aggregation, leading to cell death. Notably, hirunipin 2 effectively inhibits biofilm formation, eradicates preformed biofilms, and synergizes with antibiotics against multidrug‐resistant Acinetobacter baumannii (MDRAB) by enhancing membrane permeability. Additionally, hirunipin 2 significantly suppresses pro‐inflammatory cytokine expression in LPS‐stimulated macrophages, highlighting its anti‐inflammatory properties. These findings highlight hirunipin 2 as a strong candidate for developing novel antibacterial, anti‐inflammatory, and antibiofilm therapies, particularly against multidrug‐resistant bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular & Molecular Medicine, School of Medicine, Chosun University, Gwangju, 61452, Republic of Korea.
- Gwangju Center, Korea Basic Science Institute (KBSI), Gwangju, 61751, Republic of Korea.
- Department of Animal Science, Chonnam National University, Gwangju, 61186, South Korea.
- Department of Biomedical Sciences, Graduate School, Chosun University, Gwangju, 61452, Republic of Korea.
- Department of Biological Sciences and Biotechnology, College of Natural Sciences, Chungbuk National University, Cheongju, Chungbuk, 28644, Republic of Korea.
- Department of Chemistry, Chonnam National University, Gwangju, 61186, Republic of Korea.
ORCID-Profile: Sung-Jin Cho
Förderung
- National Research Foundation of Korea
- Ministry of Education
- Ministry of Science and ICT
- Commercialization Promotion Agency for R&D Outcomes (COMPA)
- Korea Basic Science Institute
- National Institute of Biological Resources (NIBR), funded by the Ministry of Environment (MOE)
- ABC-based Regenerative BioTherapeutics (ABC project) grant funded by the Korea government (the Ministry of Science and ICT)
- Global-Learning & Academic Research Institution for Master's·PhD students, and Postdocs (LAMP) Program of the NRF grant funded by the Ministry of Education
Zitieren
APA
Kumar, S. D., Park, J., Radhakrishnan, N. K., Aryal, Y. P., Jeong, G. H., Pyo, I. H., Ganbaatar, B., Lee, C. W., Yang, S., Shin, Y., Subramaniyam, S., Lim, Y. J., Kim, S. H., Lee, S., Shin, S. Y., & Cho, S. J. (2025). Novel Leech Antimicrobial Peptides, Hirunipins: Real‐Time 3D Monitoring of Antimicrobial and Antibiofilm Mechanisms Using Optical Diffraction Tomography. Advanced Science, 12(10). https://doi.org/10.1002/advs.202409803
Vancouver
Kumar SD, Park J, Radhakrishnan NK, Aryal YP, Jeong GH, Pyo IH, et al. Novel Leech Antimicrobial Peptides, Hirunipins: Real‐Time 3D Monitoring of Antimicrobial and Antibiofilm Mechanisms Using Optical Diffraction Tomography. Advanced Science. 2025;12(10). doi:10.1002/advs.202409803
BibTeX
@article{Kumar2025,
author = {Kumar, S Dinesh and Park, Jeongwon and Radhakrishnan, Naveen Kumar and Aryal, Yam Prasad and Jeong, Geon-Hwi and Pyo, In-Hyeok and Ganbaatar, Byambasuren and Lee, Chul Won and Yang, Sungtae and Shin, Younhee and Subramaniyam, Sathiyamoorthy and Lim, Yu-Jin and Kim, Sung-Hak and Lee, Seongsoo and Shin, Song Yub and Cho, Sung-Jin},
title = {Novel Leech Antimicrobial Peptides, Hirunipins: Real‐Time 3D Monitoring of Antimicrobial and Antibiofilm Mechanisms Using Optical Diffraction Tomography},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {10},
doi = {10.1002/advs.202409803}
}
EUVIMED